Company intelligence
Law Offices of Scott Glovsky
About Law Offices of Scott Glovsky
The Law Offices of Scott Glovsky in Pasadena was founded in 1999 and specializes in insurance bad faith, catastrophic personal injury, and health-related litigation. Scott Glovsky started the firm to help ordinary people suffering because of the negligent and bad acts of organizations and corporations. Scott’s clients have included health insurance policyholders denied needed care for brain injuries and organ transplants, seniors who have been physically and financially abused and numerous accident victims harmed by faulty products and negligent drivers.
Verified activity
Signals from Law Offices of Scott Glovsky
5 published signals
Research & Knowledge
Law Offices of Scott Glovsky reported that the FDA recently approved daraxonrasib (Rasonque), a once-daily pill for patients with metastatic pancreatic cancer who have already received chemotherapy.
Reported by Law Offices of Scott Glovsky
Legal & Regulatory
Law Offices of Scott Glovsky reported that a patient facing serious autoimmune and neurological conditions experienced repeated health insurance denials for treatments recommended by her doctors, with one treatment approved for 12 months after a peer-to-peer review challenged the IVIG denial.
Reported by Scott Glovsky
Research & Knowledge
Law Offices of Scott Glovsky notes that Medicare beneficiaries could see significant changes in 2027, including a maximum Part D deductible increase from $615 to $700 and an annual out-of-pocket cap for covered prescription drugs rising from $2,100 to $2,400.
Reported by Scott Glovsky
Legal & Regulatory
Law Offices of Scott Glovsky reported that residents of Troy, New York, successfully pushed back against plans to close the city’s only birthing center after its parent health system cited financial losses.
Reported by Law Offices of Scott Glovsky
Legal & Regulatory
Law Offices of Scott Glovsky reported that Florida Attorney is suing pharmacy benefit managers Express Scripts and Prime Therapeutics over a 2019 agreement allowing Prime to adopt Express Scripts’ lower pharmacy reimbursement rates, alleging it constitutes illegal price fixing and violates Florida antitrust laws.
Reported by Scott Glovsky